Access · Insurance & coverage

About the Insurance & coverage category

Access › Insurance & coverage insurance prior authorisation appeals

Pinned Wiki

owen.bradyTL4 Moderator5 Apr 2026#1

Community wiki post. Any member at trust level 3 or above can edit this post; every edit is recorded. Last edited by owen.brady on 30 Jun 2026.

30 Jun 2026 — owen.brady: Replaced an unsourced figure with the published one and cited it.

Editors: owen.brady, mira.patel, hana.sato

Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Prior authorisation, appeals, denial letters, and documentation that helps.

This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope described here has drifted from what actually gets posted, edit it rather than starting a topic about it.

What belongs here

Questions specific to insurance & coverage, with the units and the context stated.
Reports and datasets, with the collection method stated.
Disagreement about the substance, conducted in public.

What belongs elsewhere

Anything urgent belongs in Safety, immediately, and not here.
Anything about how this site works belongs in Meta.
Requests for a maintained page belong in Wiki requests.

Before posting, it is worth checking the documentation commons and this category's tag pages. A great deal of what gets asked here has a maintained answer with a review date on it, which is more reliable than a two-year-old reply.

17 likes 4mo

hana.satoTL4 Moderator14 Apr 2026#2

Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Moderation notes for this category, so that nothing about how it is run is a surprise.

Topics get moved into and out of here regularly. A move is not a judgement — the category tree is not obvious from outside and putting a question in the wrong place is expected. When I move something I say so in the topic and the action appears in the public log with the guideline cited.

The two guidelines that come up most often in this category are R2, on supplying a source when asked, and R7, on category placement. Neither is used punitively.

2 likes 3mo

dr_seongTL3Physician20 Apr 2026#3

As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic list shows you what is recent. The tags show you what is settled.

0 likes 3mo

f.weissTL225 Apr 2026#4

Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for exactly those. Happy to make the edit myself if nobody objects, with a revision note.

20 likes 3mo

d.ferreiraTL230 Apr 2026#5

dr_seong, post #3: As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic list shows you what is recent. The tags show you what is settled. Go to post

Quantity limits are a separate decision from coverage and have their own exception route.

13 likes in reply to #3 3mo

bias_varianceTL4Biostatistician5 May 2026#6

Post #5 is the version of this I will quote in future. One addition.

Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and appeals based on the covered indication work better.

5 likes 3mo

c.chowdhuryTL29 May 2026#7

Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.

Stating my assumptions rather than smuggling them in.

0 likes 3mo

This topic was referenced in

[2026 update] An appeal that failed, and what I would do differentlyAccess › Insurance & coverage · 159 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Reading a denial letter as a specification for your appeal Access › Insurance & coverage appeals prior authorisation insurance Closed Reading a denial letter as a specification for your appeal Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about reading a…		3	30k	12mo
Prior authorisation: what the criteria usually require Access › Insurance & coverage prior authorisation formulary appeals insurance Solved On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. I would like to know what people here actually do about prior authorisation, as…	+9	13	3.2k	17mo
Revisiting: Reading a denial letter as a specification for your appeal Access › Insurance & coverage prior authorisation insurance formulary appeals Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking about Reading a denial letter on behalf of…	+125	138	9.4k	10mo
Coverage for the indication versus for the drug Access › Insurance & coverage insurance formulary appeals prior authorisation Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. The question about coverage that I actually want answered is the second one below. The…	+70	79	18k	14mo
Peer-to-peer review: what actually happens on the call — one year on Access › Insurance & coverage appeals formulary insurance Peer-to-peer review: what actually happens on the call — one year on — setting out what I have, and where I think it stops being reliable. The question about Peer-to-peer review that I actually want answered…	+2	6	41k	5mo

Related topics — sharing the tags insurance, prior authorisation, appeals

Topic	Participants	Replies	Views	Activity
Coverage in the US: a map of the usual obstacles Regional › North America FDA insurance telehealth compounding Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…	+46	50	7.9k	5mo
Coming back to: Preparing for an appointment: one page, three questions Clinical › Prescriber conversations telehealth beginner friendly type 2 diabetes prior authorisation Preparing for an appointment: one page, three questions — setting out what I have, and where I think it stops being reliable. A question about how to describe something to a clinician rather than about the…	+51	56	1.4k	2d
Revisiting: US compounding rules and how they changed Regional › North America insurance telehealth compounding On the subject in the title: Revisiting: US compounding rules and how they changed Working notes rather than a conclusion. Regional question, dated February 2026, because everything in this category expires.…	+5	9	26k	23mo
An appeal that failed, and what I would do differently Access › Insurance & coverage insurance appeals prior authorisation An appeal that failed, and what I would do differently Writing it up because I had to work it out twice and would rather nobody else did. Asking about appeal directly, because I have read four threads on it…	+4	8	125	12mo
Coverage for the indication versus for the drug — a second dataset Access › Insurance & coverage prior authorisation appeals formulary insurance Solved Closed On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and…	+46	50	41k	16mo

Sponsored PeptideMeter — peptide analytics and supplier verificationPurity analysis and structured supplier verification, published as dated records rather than scores. Referenced throughout our sourcing documentation.View analytics →